Search

everythinglearnresearchcommunity

for

Search:↓

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Skin reactions from cancer treatments might predict how well the treatments work.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.